ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and AdolescentsArie Levine, David C. Wilson, Paolo Lionetti et al.|Journal of Pediatric Gastroenterology and Nutrition|2013Cited by 1.4k
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in ChildrenJeffrey S. Hyams, Robert N. Baldassano, Wallace Crandall et al.|Gastroenterology|2006Cited by 872
Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)Yvan Vandenplas, Tobias G. Wenzl, Colin D. Rudolph et al.|Journal of Pediatric Gastroenterology and Nutrition|2009Cited by 736
Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative ColitisJeffrey S. Hyams, Anne M. Griffiths, Lakshmi Damaraju et al.|Clinical Gastroenterology and Hepatology|2011Cited by 282
Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extensionJeffrey S. Hyams, Robert N. Baldassano, Thomas D. Walters et al.|Current Medical Research and Opinion|2011Cited by 109